CN1659178A - 6、11二环红霉素衍生物 - Google Patents

6、11二环红霉素衍生物 Download PDF

Info

Publication number
CN1659178A
CN1659178A CN038136236A CN03813623A CN1659178A CN 1659178 A CN1659178 A CN 1659178A CN 038136236 A CN038136236 A CN 038136236A CN 03813623 A CN03813623 A CN 03813623A CN 1659178 A CN1659178 A CN 1659178A
Authority
CN
China
Prior art keywords
formula
attached
taken together
previously defined
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN038136236A
Other languages
English (en)
Chinese (zh)
Inventor
柯日新
王国强
林·特玛·普汉
牛德强
邱遥龄
恩哈·胡·沃
杰伊·裘德桑·法默
侯英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enanta Pharmaceuticals Inc
Original Assignee
Enanta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharmaceuticals Inc filed Critical Enanta Pharmaceuticals Inc
Publication of CN1659178A publication Critical patent/CN1659178A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN038136236A 2002-05-13 2003-05-13 6、11二环红霉素衍生物 Pending CN1659178A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14439602A 2002-05-13 2002-05-13
US10/144,396 2002-05-13
US10/436,622 2003-05-13
US10/436,622 US7129221B2 (en) 2002-05-13 2003-05-13 6,11-bicyclic erythromycin derivatives

Publications (1)

Publication Number Publication Date
CN1659178A true CN1659178A (zh) 2005-08-24

Family

ID=34067652

Family Applications (1)

Application Number Title Priority Date Filing Date
CN038136236A Pending CN1659178A (zh) 2002-05-13 2003-05-13 6、11二环红霉素衍生物

Country Status (6)

Country Link
US (1) US7129221B2 (enExample)
EP (1) EP1509538A1 (enExample)
JP (1) JP2005536465A (enExample)
KR (1) KR100661973B1 (enExample)
CN (1) CN1659178A (enExample)
NZ (1) NZ536402A (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
AU2004217919A1 (en) * 2003-03-05 2004-09-16 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using the same
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US20070270357A1 (en) * 2003-11-18 2007-11-22 Farmer Jay J Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
EP1723159B1 (en) * 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
US20060058247A1 (en) * 2004-09-16 2006-03-16 Yujiro Hata Methods and compositions for treating cystic fibrosis
CA2598139A1 (en) * 2005-02-21 2006-08-24 Alpharma Aps Method for the production of macrolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
JP2009539866A (ja) * 2006-06-05 2009-11-19 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換エリスロマイシンアナログの調製および有用性
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
EP2203435B1 (en) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. 6, 11-bridged biaryl macrolides
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
WO2009137787A1 (en) 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
WO2009137739A1 (en) * 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of o-[5-[4-amino-thiazol-2-yl]-pyridin-2-ylmethyl]-hydroxylamine
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
WO2010096051A1 (en) * 2009-02-18 2010-08-26 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl amide macrolide derivatives
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
CN116947687B (zh) * 2022-04-14 2025-07-18 帕潘纳(北京)科技有限公司 吡唑类除草剂中间体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
EP0559896B1 (en) 1990-11-28 1997-08-27 Taisho Pharmaceutical Co. Ltd 6-o-methylerythromycin a derivative
ATE135707T1 (de) 1992-04-22 1996-04-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolid a derivate
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2738571B1 (fr) 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
CO4990972A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de eritromicina en puente 6,11
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
CA2370743A1 (en) 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives

Also Published As

Publication number Publication date
US20040053861A1 (en) 2004-03-18
KR20050003454A (ko) 2005-01-10
JP2005536465A (ja) 2005-12-02
NZ536402A (en) 2006-08-31
EP1509538A1 (en) 2005-03-02
US7129221B2 (en) 2006-10-31
KR100661973B1 (ko) 2006-12-28

Similar Documents

Publication Publication Date Title
CN1659178A (zh) 6、11二环红霉素衍生物
CN1241931C (zh) 大环内酯抗感染药物
CN1244202A (zh) 三环红霉素衍生物
CN1216064C (zh) 6－o－取代的红霉素衍生物的制备方法
CN1273475C (zh) 具有抗细菌活性的6－0－取代的酮基内酯类化合物
CN100335491C (zh) 具有抗炎活性的大环内酯化合物
CN1240707C (zh) 2－卤代－6－0－取代的酮内酯衍生物
CN1269833C (zh) 新的芳香酰胺、其制备方法以及作为药物的应用
CN1065069A (zh) 新的红霉素衍生物的制备方法
CN1633444A (zh) 6－11双环酮大环内酯衍生物
CN1259135A (zh) 9－肟红霉素衍生物
CN1351608A (zh) 13－甲基红霉素衍生物
CN1343215A (zh) 具有抗菌活性的6－o－取代大环内酯类化合物
CN1630661A (zh) 具有抗菌活性的大环内酯类化合物
CN1271363A (zh) 具有抗菌活性的3’－n－修饰的6－o－取代的红霉素酮基内酯衍生物
CN1278266A (zh) 6,11－桥连红霉素衍生物
CN1780846A (zh) 双官能杂环化合物及其制备和使用方法
CN1213055C (zh) 核糖取代的新芳族酰胺、其制备方法及其作为药剂的用途
CN1040877C (zh) 红霉素的新衍生物、它们的制备方法和作为药物的应用
CN1308342C (zh) 核糖取代的芳族化合物,其制备方法和作为药物的应用
CN1729200A (zh) 大环内酯类
CN1382150A (zh) 潮霉素衍生物
CN1849328A (zh) 新型14和15元环化合物
HK1081557A (en) 6, 11 bicyclic erythromycin derivatives
CN1950388A (zh) 大环化合物以及其制作和使用方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1081557

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20050824

C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1081557

Country of ref document: HK